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Gastrointestinal bacterial infections are a common 
health problem and have serious implications   
because of their epidemic potential (Tassios and 
Kerr,  2010).  Enteric  pathogens  raise  additional 
concerns because recent globalization of the food 
supply increases the chance of outbreaks and the 
potential for bioterrorism. Most clinically signifi-
cant enteric pathogens, such as Yersinia, Salmonella, 
Vibrio,  or  Shigella,  are  Gram-negative  bacteria 
which have evolutionarily acquired an ability to 
evade host immune defenses (Miao and Miller, 
1999; Brodsky and Medzhitov, 2008; Arnold 
et al., 2010). The strategies used for immune eva-
sion mainly target innate immunity, highlighting 
the importance of the innate immune system in 
intestinal host defense mechanisms. Although ex-
tensive studies have revealed the virulence factors 
of these pathogens, it is still unclear how the host 
innate immune cells formulate effective intestinal 
defense to these pathogens.
Pathogens are recognized by the host in-
nate immune system through Toll-like receptors 
(TLRs),  which  induce  intracellular  signaling 
mainly  through  two  adapter  molecules,  my-
eloid  differentiation  factor  88  (MyD88)  or 
toll/interleukin 1 receptor domain-containing 
adapter  inducing  IFN-  (TRIF).  Although 
MyD88 is used by most TLRs, the TRIF path-
way can only be recruited by TLR4 and TLR3. 
The MyD88 pathway strongly induces NF-B 
activation  and  proinflammatory  cytokine  se-
cretion  associated  with  pathogen  clearance 
(Lebeis et al., 2009). The TRIF pathway, in 
contrast,  induces  type  I  IFNs  and  slower   
NF-B activation and has largely been associated 
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Toll-like receptor 4 (TLR4), which signals through the adapter molecules myeloid differen-
tiation factor 88 (MyD88) and toll/interleukin 1 receptor domain-containing adapter 
inducing IFN- (TRIF), is required for protection against Gram-negative bacteria. TRIF is 
known to be important in TLR3-mediated antiviral signaling, but the role of TRIF signaling 
against Gram-negative enteropathogens is currently unknown. We show that TRIF signaling 
is indispensable for establishing innate protective immunity against Gram-negative Yersinia 
enterocolitica. Infection of wild-type mice rapidly induced both IFN- and IFN- in the 
mesenteric lymph nodes. In contrast, TRIF-deficient mice were defective in these IFN re-
sponses and showed impaired phagocytosis in regional macrophages, resulting in greater 
bacterial dissemination and mortality. TRIF signaling may be universally important for 
protection against Gram-negative pathogens, as TRIF-deficient macrophages were also 
impaired in killing both Salmonella and Escherichia coli in vitro. The mechanism of TRIF-
mediated protective immunity appears to be orchestrated by macrophage-induced IFN- 
and NK cell production of IFN-. Sequential induction of IFN- and IFN- leads to ampli-
fication of macrophage bactericidal activity sufficient to eliminate the invading pathogens 
at the intestinal interface. Our results demonstrate a previously unknown role of TRIF in 
host resistance to Gram-negative enteropathogens, which may lead to effective strategies 
for combating enteric infections.
©  2011  Sotolongo  et  al.  This  article  is  distributed  under  the  terms  of  an   
Attribution–Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first 
six months after the publication date (see http://www.rupress.org/terms). After 
six months it is available under a Creative Commons License (Attribution– 
Noncommercial–Share Alike 3.0 Unported license, as described at http://creative-
commons.org/licenses/by-nc-sa/3.0/).
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and livers of TrifLps2 mice starting 48 h after infection, which 
were not observed in WT mice (Fig. 1 C). The number of 
colonies detected in the spleens of TrifLps2 mice was strikingly 
higher than in WT mice (P = 0.0002), supporting bacterial dis-
semination and Yersinia sepsis as the cause of death (Fig. 1 D). 
Consistently,  there  were  significantly  higher  numbers  of   
Y. enterocolitica in the MLNs and PPs of TrifLps2 mice compared 
with WT mice, indicating that there is a greater regional burden 
of Y. enterocolitica in TrifLps2 mice leading to more efficient escape 
from the intestine and dissemination to distant organs. TRIF 
may be particularly important after oral infection. This is a result 
of the fact that intravenous Y. enterocolitica infection of WT and 
TrifLPS2 mice showed similar Y. enterocolitica titers in the spleen 
5  d  after  infection  (WT  3.9  ±  0.1  vs.  TrifLPS2  4.1  ±  0.2 
Log10CFU/g, n = 8 each, P = 0.39). Therefore, the TRIF path-
way may play a significant role in establishing a regional defense 
mechanism in the intestine during the first 48 h of infection.
TRIF is required for initiation of protective immune 
responses to Y. enterocolitica in PPs
Given the striking differences in Y. enterocolitica dissemination 
between WT and TrifLps2 mice at 48 h after infection, we 
examined local events in the intestine after oral infection. 
with antiviral responses (Yamamoto et al., 2003; Guo and 
Cheng, 2007). Although TLR4 can signal through either 
pathway, the majority of LPS-induced genes in macrophages 
appear  to  use  a  MyD88-independent  pathway,  suggesting 
that the TRIF pathway may play a role in responses to 
Gram-negative  pathogens  (Björkbacka  et  al.,  2004). These 
observations led us to question whether TRIF signaling has 
been overlooked as a mediator of host defense against enteric 
pathogens. Emerging evidence has demonstrated that TRIF is 
required for host resistance against pulmonary infection with 
multiple Gram-negative pathogens (Jeyaseelan et al., 2007; 
Cai et al., 2009), whereas intestinal protective immunity me-
diated through the TRIF pathway has not been studied.
In the current study, we used a well established animal 
model of oral Yersinia enterocolitica infection, which recapitu-
lates many features of the human disease (Trülzsch et al., 
2007). We found that TRIF-deficient (TrifLPS2) mice, which 
carry a frameshift mutation in the Trif gene, have impaired 
resistance to oral Y. enterocolitica infection. The TrifLPS2 mice 
showed defective inflammatory responses in Peyer’s patches 
(PPs)  and  rapid  systemic  dissemination  of  Y.  enterocolitica. 
Mechanistically, we found an unexpectedly important role for 
TRIF  in  the  bactericidal  function  of  macrophages  against 
Gram-negative pathogens. During Y. enterocolitica infection, 
TRIF-dependent protective immunity is mediated through 
an induction of IFN- from infected macrophages in the 
mesenteric LN (MLN). This induction of IFN- accelerates 
bactericidal activity of macrophages directly as well as indi-
rectly via inducing IFN- from adjacent NK cells. Exogenous 
stimulation of the TRIF pathway through polyinosinic:poly-
cytidylic acid (poly I:C) evoked protective immunity against 
Y. enterocolitica infection in WT mice. The protective effect of 
poly I:C was also observed in an oral infection with another 
Gram-negative enteric pathogen Salmonella typhimurium. Thus,   
TRIF-mediated protective immunity against enteric bacterial 
infection is mainly mediated by macrophages, which act as   
regional filters of infectious enteropathogens. Elucidation of 
TRIF-dependent  intestinal  immune  regulation  could  lead   
to more effective immune-based prevention and/or treatments 
for enteric infectious diseases.
RESULTS
TRIF-deficient mice have increased susceptibility to oral 
infection with Y. enterocolitica
To examine the role of the TRIF pathway in the host re-
sponse to Y. enterocolitica infection, WT and TrifLps2 mice were 
orally inoculated with 2 × 107 CFU Y. enterocolitica. TrifLps2 
mice showed greater body weight loss than WT mice (Fig. 1 A). 
Furthermore, 10 out of 15 (66.7%) TrifLps2 mice died, whereas 
10 out of 11 (90.9%) of WT mice survived throughout the 
experiment (Fig. 1 B). Almost half of the TrifLps2 mice died 
within 3 d of infection, indicating a specific role for TRIF in 
the early stage of infection.
To explore the cause of early mortality in TrifLps2 mice, his-
tology of the infected mice was evaluated daily during the first 
3 d of infection. Multiple abscesses were found in the spleens 
Figure 1.  TRIF deficiency results in greater mortality and higher 
susceptibility to bacterial dissemination in the Y. enterocolitica 
infection model. WT and TrifLps2 mice were orally infected with 2 × 107 
CFU Y. enterocolitica. (A) Weight loss in WT and TrifLps2 mice during  
Y. enterocolitica infection (n = 8 each; *, P < 0.05). Combined data from 
four independent experiments are shown. Error bars, SEM. (B) Kaplan 
Meier survival curves for infected WT (n = 11) and TrifLps2 mice (n = 15). 
Combined data from four independent experiments are shown (*, P < 0.01).  
(C) H&E staining of the spleen and liver taken 48 h after infection. Arrow-
heads indicate abscesses. Representative pictures from six mice of each 
genotype. Bars, 100 µm. (D) Y. enterocolitica titers in the spleens, MLNs, 
and PPs of individual infected WT and TrifLps2 mice taken 48 h after infec-
tion. Pooled data from three independent experiments are shown (n = 6 
each; *, P < 0.05). Horizontal bars indicate mean.JEM Vol. 208, No. 13 
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Although the majority of the macrophages in PPs of WT 
mice were red fluorescent (Y. enterocolitica) positive, few macro-
phages  in TrifLps2  mice  were  positive  for  Y.  enterocolitica  
and there appeared to be more extracellular Y. enterocolitica 
foci in PPs of TrifLps2 mice than WT mice. In addition, real-
time  PCR  for  the  chemokines  IP-10  (CXCL10),  KC 
(CXCL1), and MIP-2 (CXCL2), which can be induced   
by TRIF-mediated TLR signaling in innate immune cells 
(Jeyaseelan et al., 2007; Power et al., 2007; De Filippo et al., 
2008; Kelly-Scumpia et al., 2010), demonstrated impaired ex-
pression of IP-10 but similar expression of MIP-2 and KC 
mRNA in PPs from TrifLps2 mice compared with WT mice 
(Fig. 2 E). IP-10 has been shown to be a macrophage early re-
sponse gene and a potent chemoattractant for activated T cells, 
NK cells, and neutrophils in the face of bacterial pathogens 
(Jeyaseelan et al., 2007; Power et al., 2007; De Filippo et al., 
2008; Kelly-Scumpia et al., 2010). In our system, TRIF- 
mediated IP-10 would be important for neutrophil recruit-
ment to PPs because treatment of WT mice with a blocking 
anti–IP-10 antibody decreased Gr1+ cell population in PPs to 
Y. enterocolitica initially colonizes PPs (Autenrieth and Firsching, 
1996). Histology of PPs showed an acute inflammatory infil-
trate, occasional ulcerations, and small abscesses in both WT 
and TrifLps2 mice (Fig. 2 A). When we analyzed cellular pop-
ulations in PPs, significantly fewer Gr1+ cells and CD161+ 
(NK1.1) cells were observed in TrifLps2 mice compared with 
WT mice (Fig. 2 B). As a result, histological severity of in-
flammation was significantly less in TrifLps2 mice than in WT 
mice, suggesting an impaired local immune response in 
TrifLps2 mice (Fig. 2 C). It seems unlikely that these differ-
ences are a result of developmental differences of PPs be-
tween WT and TrifLps2 mice because baseline PPs in TrifLps2 
mice showed normal cell populations (Table S1).
Because macrophages are a primary target of Y. entero­
colitica and play a crucial role in establishing local immune re-
sponses (Bergsbaken and Cookson, 2007), we addressed whether 
macrophages  from  TrifLps2  mice  normally  interacted  with   
Y. enterocolitica that invade PPs. The interaction between Y. entero­
colitica and macrophages in PPs were examined at 48 h after in-
fection with red fluorescent–labeled Y. enterocolitica (Fig. 2 D). 
Figure 2.  TrifLps2 mice exhibit a defective immune response in PPs in response to Y. enterocolitica infection. (A) H&E sections of PPs of WT and 
TrifLps2 mice 48 h after infection. Representative pictures from six mice of each genotype. A PP from an uninfected WT mouse is shown for comparison 
(left). Bars, 200 µm. Bacterial foci are indicated by circled area (right). Bars, 50 µm. (B) Cell population analysis in PPs of Y. enterocolitica–infected WT and 
TrifLps2 mice. Single cell suspensions of PPs were analyzed by FCM 48 h after infection (gathered data from two independent experiments, n = 4 each;  
*, P < 0.05; error bars, SEM). (C) Histological scoring in WT and TrifLps2 mice 48 h after infection (combined data from three independent experiments,  
n = 6 each; *, P < 0.05; error bars, SEM). (D) Interaction of macrophages in PPs (F4/80: FITC, green) with infected Y. enterocolitica (SYTO83, red) 48 h after 
infection. Representative pictures are of PPs from WT and TrifLps2 mice taken from one of the two independent experiments (n = 3 each). Macrophages 
positive for Y. enterocolitica are indicated by arrowheads. Extracellular Y. enterocolitica foci in TrifLps2 PPs are indicated by the arrow. Bars, 50 µm.  
(E) Real-time PCR analysis of IP-10, MIP-2, and KC expression in PPs taken 48 h after infection (n = 6 each, averages of samples from three independent 
experiments; *, P < 0.05). Control mice did not receive infection (n = 6 each). NS, not significant. Error bars, SEM. (F) FCM analysis of Gr1+ cells in PPs 48 h 
after infection. Data from WT and TrifLps2 mice that were treated with anti–IP-10 antibody and isotype control antibody are shown.2708 TRIF protects against enteric bacteria | Sotolongo et al.
function by oxidative burst in response to Y. enterocolitica in-
fection. There were significant defects in the oxidative burst 
in TrifLps2 and TLR4/ macrophages compared with WT 
macrophages (Fig. 3 B). Internalization of fluorescent-labeled 
Y. enterocolitica was also defective in both TLR4/ and 
TrifLps2  macrophages  compared  with  WT  macrophages 
(Fig. 3 C). These phagocytic defects in TrifLPS2 macrophages 
were also seen in response to E. coli and heat-inactivated   
S. typhimurium, suggesting that the TRIF pathway is required 
for multiple steps of phagocytosis against Gram-negative 
pathogens (Fig. 3 D). However, the defects are pathogen spe-
cific because TrifLPS2 macrophages showed similar ability to 
uptake polystyrene microspheres as WT macrophages (WT, 
78.9 ± 9.1% vs. TrifLps2, 78.7 ± 6.5%). Y. enterocolitica can in-
duce apoptosis in eukaryotic cells (Ruckdeschel et al., 2004), 
which may influence the result of macrophage bactericidal 
function. However, we did not see differences in caspase-3 
activities in these macrophages during infection (Fig. S2). 
These  data  demonstrate  that  multiple  aspects  of  normal   
macrophage function in the context of a Gram-negative 
pathogen require TRIF signaling, which is originated through 
TLR4 engagement.
TRIF-mediated IFN- is critical for the bactericidal function 
of Y. enterocolitica–infected macrophages
Next,  we  addressed  whether  the  impaired  bactericidal 
ability of TrifLps2 macrophages is associated with defec-
tive  cytokine  expression  in  response  to   
Y. enterocolitica. IL-12p35, TNF, and IFN- 
have been implicated in host defense against 
Y. enterocolitica infection, and IFN- is a 
primary inducible cytokine by the TRIF 
pathway (Autenrieth and Heesemann, 1992;   
the levels in TrifLps2 mice at 48 h after infection (Fig. 2 F). This 
treatment did not alter Gr1+ cell number in PPs of TrifLps2 
mice, indicating the effect was TRIF dependent. These results 
indicate that TrifLps2 mice have defects in regional macrophage 
response to invading Y. enterocolitica and chemokine IP-10 ex-
pression in PPs, which may be responsible for the impaired 
local immune responses at the primary infection site.
TRIF-deficient macrophages are defective in phagocytosis 
and intracellular killing of Gram-negative pathogens
To examine macrophage pathways involved in the elimina-
tion of Y. enterocolitica, we isolated peritoneal macrophages 
from mice deficient in TRIF, MyD88, TLR3, and TLR4 
and infected them with Y. enterocolitica in vitro at a multiplic-
ity of infection (MOI) of 1 (Wiley et al., 2006). A striking 
increase of Y. enterocolitica proliferation was found in TrifLps2 
macrophages compared with WT macrophages, indicating im-
paired bactericidal function of TrifLps2 macrophages (Fig. 3 A). 
TLR4/ but not TLR3/ macrophages also had impaired 
bactericidal function, suggesting that TLR4 was the domi-
nant TLR upstream of the TRIF pathway in this process 
(Fig. 3 A). MyD88/ macrophages had a partial bactericidal 
defect against Y. enterocolitica (P = 0.0482). Exclusion of non-
phagocytosed bacteria with gentamicin did not alter the bac-
tericidal pattern of these macrophages, indicating that TrifLps2 
macrophages had defective intracellular killing of Y. entero­
colitica (Fig. S1). We further examined the endolysosomal   
Figure 3.  TRIF is required for phagocytosis 
and intracellular killing of Gram-negative 
pathogens. (A) Bactericidal assay of infected peri-
toneal macrophages (MOI: 1). Y. enterocolitica 
growth during 6 h of incubation is shown as fold 
increase of CFU (*, P < 0.05; error bars, SEM). Rep-
resentative data from five repeated experiments are 
shown (n = 3 each). (B) Oxidative burst of infected 
macrophages (MOI: 50) from WT, TLR4/, and 
TrifLps2 mice. Combined data from three indepen-
dent experiments is shown (n = 9 each; *, P < 0.01). 
Data are expressed as relative light units (RLU). 
Error bars, SEM. (C) Phagocytic internalization of 
fluorescent-labeled Y. enterocolitica by macro-
phages. Macrophages were infected with Y. entero-
colitica for 30 min (MOI: 50). FCM (left) and 
microscopic (right) analysis are shown. Data are 
representative from three repeated experiments  
(n = 3 each). Bars, 50 µm. (D) Phagocytosis and 
oxidative burst of macrophages in response to  
E. coli and S. typhimurium (MOI: 50). Representative 
data from three repeated experiments are shown  
(n = 9; *, P < 0.01 each). Error bars, SEM.JEM Vol. 208, No. 13 
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systemic bacterial dissemination in murine models of enteric 
infection (Macpherson and Uhr, 2004; Westphal et al., 2008; 
Voedisch et al., 2009). Because there was a striking Y. entero­
colitica dissemination in TrifLPS2 mice but not in WT mice, we 
examined in vivo cytokine gene expression in the MLN, taken 
48 h after infection. TrifLps2 mice exhibited significantly lower 
mRNA levels of IFN- and IFN- in the MLN than WT 
mice, whereas the mRNA levels of IL-12p35 and TNF was 
similar between WT and TrifLps2 mice (Fig. 5 A). We con-
firmed these differential inductions of IFNs between WT and 
TrifLPS2 mice by examining protein levels in MLN cell suspen-
sions harvested 48 h after infection (Fig. 5 B). The mRNA ex-
pression of these cytokines in PPs was very low and there were 
no differences between WT and TrifLps2 mice (Fig. S3).
Immunofluorescent labeling of IFN- demonstrated that 
F4/80+ cells, a phenotype indicative of macrophages, were 
the main source of IFN- in the MLN of infected WT mice 
(Fig. 5 C). A small portion of these IFN-–expressing F4/80+ 
cells was also CD11c+, a phenotype attributed to myeloid 
DCs (Fig. 5 C). Flow cytometric (FCM) analysis demon-
strated that 23.3 ± 1.0% of total IFN-–expressing cells were 
F4/80+CD11c+ DCs (Fig. 5 C). In contrast, the majority of 
IFN-–expressing  cells  in  the  MLN  were  CD3CD161+ 
(NK1.1) NK cells (Fig. 5 C).
The decrease of IFN- production in TrifLps2 mice was 
reflected even in the serum levels of IFN-, suggesting a   
possible contribution of IFN- to the systemic immune re-
sponses during enteric Y. enterocolitica infection (Fig. 5 D). In 
contrast, serum IFN- was not detectable in infected TrifLps2 
or WT mice (unpublished data). Because innate cytokine re-
sponses may differ between regional and systemic compart-
ments, mRNA expression of IL-12p35, TNF, IFN-, and 
IFN- in the MLN and spleen was kinetically compared after 
infection. We could only follow up to day 5 after infection as 
a result of the high mortality of TrifLps2 mice during the infec-
tion (Fig. 1 B). The expression of these cytokines showed a 
peak at 72 h of infection and was greater in the MLN than 
the spleen. Striking induction of IFN- was seen in the MLN 
and spleen of WT mice during 48 to 72 h after infection, but 
this induction was defective in TrifLps2 mice (Fig. 5 E). Again, 
IFN-–expressing cells in the spleen were F4/80+ cells, but 
this time the population did not contain the CD11c+ subset 
(Fig. 5 F). In contrast, major induction of IFN- was seen 
typically in the MLN of WT mice from 48 h after infection 
and continued afterward (Fig. 5 E). This induction of IFN- 
was defective in TrifLps2 mice. IFN- expression in the spleen 
was about half of its expression in the MLN and there were 
no differences between WT and TrifLps2 mice at any time 
points (Fig. 5 E). IL-12p35 induction in the MLN was similar 
between WT and TrifLps2 mice throughout this time course. 
The expression pattern of TNF in both MLN and spleen was 
similar to the IL-12p35 expression in WT mice, but signifi-
cantly higher expression of splenic TNF was found in surviving 
TrifLps2 mice compared with WT mice after 72 h of infection 
(Fig. 5 E). These results suggest that regional TRIF signaling 
in macrophages robustly induces both local and systemic 
Autenrieth et al., 1994; Bohn and Autenrieth, 1996). In vitro 
infected WT macrophages exhibited striking induction of 
IFN-, but this induction of IFN- was completely ab-
sent in TLR4/ and TrifLps2 macrophages (Fig. 4 A). In 
contrast, induction of IL-12p35, TNF, and IFN- in re-
sponse to Y. enterocolitica infection was not observed in those 
macrophages (Fig. 4 A).
IFN- can enhance phagocytic activity in paracrine and auto-
crine ways (Vogel et al., 1983; Ellermann-Eriksen, 1993). We 
tested the hypothesis that the defect in bactericidal function in 
TrifLps2 macrophages was a result of the impaired IFN- produc-
tion. Addition of recombinant IFN- improved Y. enterocolitica 
bactericidal activity of TLR4/ and TrifLps2 macrophages to WT   
level (Fig. 4 B). These results highlight an important role of 
IFN- induction by TLR4-mediated TRIF activation to elicit 
macrophage bactericidal activity during Y. enterocolitica infection.
TRIF promotes early induction of IFNs in the MLN during  
Y. enterocolitica infection
Although PPs are the main portal of entry for many enteric 
pathogens, the MLN has been implicated in prevention of 
Figure 4.  TRIF-induced IFN- is crucial for elimination of Y. entero-
colitica by macrophages. (A) Real-time PCR analysis of cytokine expression 
in control and infected macrophages. Peritoneal macrophages were infected 
with Y. enterocolitica for 5 h (MOI: 20). Combined data from three indepen-
dent experiments (n = 9 each; *, P < 0.0001 by ANOVA; NS, not significant). 
Error bars, SEM. (B) Bactericidal assay of infected macrophages with and 
without 100 U/ml IFN- (MOI: 1). Data are obtained from three independent 
experiments (n = 9 each; *, P < 0.0001, ANOVA). Error bars, SEM.2710 TRIF protects against enteric bacteria | Sotolongo et al.
Figure 5.  Defective induction of IFNs in the MLNs of TrifLps2 mice after Y. enterocolitica infection. (A) Real-time PCR analysis of IFN-, IFN-, 
Il-12p35, and TNF expression in the MLNs taken from control and 48 h after infection of WT and TrifLps2 mice. Averages of samples from three indepen-
dent experiments (n = 6 each; *, P < 0.0001). Error bars, SEM. NS, not significant. (B) IFN production by MLN cell suspensions harvested 48 h after infec-
tion. The protein levels of IFN- and IFN- in the supernatants were measured by ELISA assays after an additional 48 h of incubation in vitro. Combined 
data from three independent experiments (n = 6 each; *, P < 0.001). Error bars, SEM. (C) Immunofluorescent and FCM analyses of IFN-– and IFN-–
expressing cells in the MLN taken from infected WT mice 48 h after infection. IFN-–expressing cells positive for F4/80 are indicated by the arrowhead. 
IFN-–expressing cells positive for CD11c are indicated by the arrow. Bars: (top and middle) 10 µm; (bottom) 5 µm. Representative pictures from infected 
WT mice (n = 4 from two independent experiments). FCM analysis shows that 76.2 ± 1.1 and 23.3 ± 1.0% of IFN-–expressing cells are macrophages and 
myeloid DCs, respectively. Isotype control data (biotin rat IgG with PE streptavidin and APC-hamster IgG within IFN-–positive cells) used for flow setting 
is shown (right). In addition, 71.5 ± 2.8% of IFN-–expressing cells are NK cells. 4.1 ± 0.3% of IFN-–expressing cells are CD3+ NKT cells. Isotype control 
data (FITC–mouse IgG and APC–hamster IgG within IFN-–positive cells) used for flow setting is shown (right). Representative data from infected WT 
mice (n = 3 each from two independent experiments). (D) Serum IFN- measured by ELISA 48 h after infection. Combined data from three independent 
experiments (n = 6 each; *, P < 0.05). Error bars, SEM. (E) Kinetic analysis of cytokine gene expression represents regional (MLN) and systemic (spleen) 
cytokine responses during Y. enterocolitica infection (real-time PCR: averages of samples from three independent experiments, n = 6 each; *, P < 0.05; 
error bars, SEM). (F) FCM analysis of splenocytes expressing IFN- in infected WT mice (n = 3 each from two independent experiments).JEM Vol. 208, No. 13 
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preincubated with poly I:C, followed by co-culturing with 
WT NK cells in the presence or absence of neutralizing anti–
IFN- antibody, and bactericidal activity was analyzed after 
removal of NK cells (Fig. 6, A and C). Co-culture of NK cells 
with poly I:C–stimulated WT macrophages showed a signifi-
cant  increase  in  bactericidal  activity,  but  this  increase  was 
abolished by neutralization of IFN- (Fig. 6 C). We did not 
see these changes of the bactericidal activity in TrifLPS2 macro-
phages, indicating that TRIF signaling in macrophages in-
duces NK cells to produce IFN-, which in turn amplifies 
bactericidal activity of macrophages. Collectively, TRIF-
mediated IFN- induction in macrophages is important to 
eliminate pathogens, not only to maintain homeostatic bacte-
ricidal function but also to summon an additive enhancement 
by NK cells through IFN- induction.
Early IFN- induction is required for expression of IFN-  
in the MLN and for preventing dissemination  
of Y. enterocolitica
To examine the importance of the rapid IFN- induction   
in host defense against Y. enterocolitica dissemination in vivo, 
we injected TrifLps2 mice with recombinant mouse IFN- 
(10,000 U i.p./d) during the first 3 d of infection. This IFN- 
treatment significantly protected TrifLps2 mice from infection, 
as all IFN-–treated mice survived throughout the experi-
ment (Fig. 7 A). None of the IFN-–treated mice had de-
tectable Y. enterocolitica colonies in the spleen at day 7 of 
infection. The bacterial titer in the MLN, but not in PPs, was 
significantly reduced in these IFN-–treated mice compared 
with PBS treated control TrifLps2 mice (Fig. 7 B). At 48 h 
after infection, significant induction of IFN- gene expres-
sion in the MLN was found in the IFN-–treated TrifLps2 
mice compared with nontreated TrifLps2 mice (Fig. 7 C). We 
also  did  the  complementary  experiment  and  found  that 
blocking IFN- signaling with an anti-IFNAR1 antibody 
IFN- responses during the initial 72 h of Y. enterocolitica 
infection, and that it is associated with sustained IFN- ex-
pression by NK cells within the MLNs to establish a TRIF-
dependent intestinal protective immunity.
TRIF-induced IFN- elicits IFN- production from NK cells,  
an additive effect on macrophage elimination of the pathogens
We demonstrated earlier that the impaired bactericidal activity 
of TrifLPS2 macrophages was a result of the defective induction 
of IFN- in response to Y. enterocolitica infection (Fig. 4 B). We 
also found a significant difference in IFN- expression be-
tween WT and TrifLPS2 mice in the MLN during Y. enterocolitica 
infection in vivo. IFN- is known to be a potent activator of 
macrophages to enhance their bactericidal function (Gordon   
et al., 2005; Matteoli et al., 2008). Because NK cells are the 
major source of IFN- in the MLN, we addressed whether 
the reduction of NK cell–induced IFN- is associated with the 
impaired ability of TrifLPS2 mice to eliminate enteric infections, 
especially in the context of macrophage bactericidal function. 
To approach this issue, we tested whether macrophages from 
WT and TrifLPS2 mice could prime NK cells to enhance the 
bactericidal activity of macrophages (Fig. 6 A).
First, we examined whether TRIF signaling in macro-
phages promotes IFN- production from NK cells in an IFN-– 
dependent fashion. WT NK cells produced a substantial 
amount of IFN- after co-culturing with poly I:C–stimulated 
WT macrophages (Fig. 6, A and B). This IFN- production 
was significantly reduced when NK cells were co-cultured 
with poly I:C-stimulated TrifLPS2 macrophages or WT macro-
phages  with  anti-IFNAR1  antibody  (Fig.  6,  A  and  B). 
Therefore,  TRIF  signaling  induces  IFN-  production  by 
macrophages,  which  then  promotes  IFN-  production  by 
NK cells. Next, we tried to determine if the NK cell–mediated 
IFN- further enhances the bactericidal function of TRIF-
activated macrophages. WT and TrifLPS2 macrophages were 
Figure 6.  TRIF-mediated IFN- induction by macrophages elicits IFN- production from NK cells which further enhances the bactericidal 
function of the macrophages. (A) Peritoneal macrophages isolated from WT and TrifLPS2 mice were stimulated with poly I:C for 6 h in the presence or 
absence of anti-IFNAR1 antibody. After washing out poly I:C, macrophages were co-cultured with WT splenic NK cells for 24 h in the presence or absence 
of neutralizing anti–IFN- antibody. After excluding NK cells, the remaining macrophages were subjected to bactericidal assay. (B) ELISA measurement of 
IFN- production from WT NK cells after co-culturing with poly I:C–stimulated macrophages in the presence or absence of anti-IFNAR1 antibody. Com-
bined data from three independent experiments (n = 6 each; *, P < 0.05). Error bars, SEM. (C) Effect of NK cell–induced IFN- on macrophage bactericidal 
activity during Y. enterocolitica infection. Combined data are from three independent experiments (n = 6 each; **, P < 0.01; *, P < 0.05). NS, not signifi-
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numbers of Y. enterocolitica in PPs from the mice that received 
poly I:C either the day before or the same day of infection 
(Fig. 8 B). Examination of Y. enterocolitica dissemination to 
partially blocked IFN- expression in Y. enterocolitica–infected 
WT mice (Fig. 7 D). Accordingly, mice that received anti-
IFNAR1 antibody showed a significant increase of Y. entero­
colitica colonization in the MLNs 48 h after infection (Fig. 7 E). 
These results indicate that TRIF-mediated induction of 
IFN- regulates expression of IFN- in the MLN during 
early stage of infection, which is important for blocking sys-
temic Y. enterocolitica dissemination.
Activation of TRIF protects WT mice  
from Y. enterocolitica infection
Given that the TRIF pathway is critical for protection against 
Y. enterocolitica dissemination, we wished to test whether stimu-
lation of the TRIF pathway protects host against Y. entero­
colitica infection. We used poly I:C to induce TRIF activation 
via TLR3. Single injection of poly I:C subcutaneously at a 
50-µg dose did not induce any histologically detectable mucosal 
changes in the intestine (not depicted) but was physiologi-
cally active, as it induced transient IRF-3 activation in the 
MLNs (Fig. 8 A). WT mice were given subcutaneous injec-
tion of 50 µg poly I:C the day before, the day of, or one day 
after oral infection of Y. enterocolitica. Control mice only   
received infection. 7 d after infection, there were reduced 
Figure 7.  IFN- protects TrifLps2 mice against Y. enterocolitica 
infection by stimulating IFN- expression in the MLN. (A) Kaplan 
Meier survival curve for infected TrifLps2 mice (TrifLps2 mice, n = 9; IFN-–
treated mice, n = 7; 10,000 U i.p/d for the first 3 d). Combined data are 
from three independent experiments. (B) Y. enterocolitica titers in PPs and 
MLNs taken after 7 d of infection. Pooled data are from three indepen-
dent experiments (*, P < 0.0001). NS, not significant. (C) Real-time PCR 
analysis of IFN- expression in the MLNs taken 48 h after infection. Com-
bined data from three independent experiments (n = 6 each; *, P < 0.005). 
Error bars, SEM. (D) Real-time PCR analysis of IFN- in the MLNs taken  
48 h after infection (100 µg i.p, the day before infection). Combined data 
from three independent experiments (n = 6 each; *, P < 0.005). Error bars, 
SEM. (E) Y. enterocolitica titers in the MLNs taken 48 h after infection. 
Pooled data from two independent experiments (n = 6 each; *, P < 0.005). 
Horizontal bars in B and E indicate mean.
Figure 8.  Activation of TRIF by poly I:C induces intestinal protective 
immunity in WT mice by enhancing IFN- expression in the MLN and 
macrophage bactericidal activity. (A) Immunoblot analysis of IRF-3 activa-
tion (phosphorylation) in the MLNs. Poly I:C–treated (24 and 48 h after injec-
tion) and nontreated WT mice are shown. Representative pictures are from 
three repeated experiments (n = 3). (B) Y. enterocolitica titers in the PPs and 
MLNs taken 7 d after infection. Pooled data are from three independent experi-
ments (*, P < 0.001 for PPs; *, P < 0.0001 for MLN). Horizontal bars indicate 
mean. (C) Real-time PCR analysis of IFN- expression in the MLNs taken 48 h 
after infection. Combined data from three independent experiments (n = 6;  
*, P < 0.05). Error bars, SEM. (D) Kaplan Meier survival curve for Trif Lps2 mice 
that received poly I:C (50 µg/mouse s.c) the day before (d-1) Y. enterocolitica 
infection. Combined data from two independent experiments (n = 6; NS, not 
significant). (E) Spleen titer results 7 d after orogastrical inoculation with 108 
CFU S. typhimurium. Pooled data from two independent experiments (n = 6 
each; *, P < 0.001). Error bars, SEM. Horizontal bars indicate mean. (F) Kaplan 
Meier survival curve for poly I:C–treated mice (n = 10 for control, n = 9 for d-1, 
n = 7 each for d0 and d+1; *, P < 0.05, combined three independent experi-
ments). (G) Kaplan Meier survival curve for poly I:C–treated (d-1) mice with or 
without anti-IFNAR antibody. Combined three independent experiments (n = 7 
for control, n = 9 each for anti-IFNAR–treated and nontreated groups, n = 5 
no-infection; *, P < 0.05). (H) Bactericidal assay of peritoneal macrophages 
(MOI: 1) with or without 5 µg/ml poly I:C. Combined data from three indepen-
dent experiments (n = 6 each; *, P < 0.001). Error bars, SEM.JEM Vol. 208, No. 13 
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species that naturally infect both man and mouse (House   
et al., 2001; Trülzsch et al., 2007). Enteric pathogens invade 
the body mainly through microfold (M) cells and colonize 
within the PPs, and then invade through draining MLNs and 
subsequently  spread  systemically  (Jepson  and  Clark,  2001; 
Oellerich et al., 2007; Westphal et al., 2008). Our results 
show a previously unappreciated property of regional macro-
phages as a crucial part of the innate protection against enteric 
pathogens and one that depends on TRIF signaling.
TRIF-deficient mice have multiple defects in the ability 
to mount an effective inflammatory response and, as a result, 
animals  succumbed  to  systemic  dissemination  of  a  Gram-
negative pathogen. First, Trif LPS2 mice were limited in the 
capacity to establish an immune response in PPs. The defec-
tive local immune response was accompanied by decreased 
neutrophil infiltration as the result of an impaired production 
of the CXC chemokine IP-10. IP-10 has been shown to be 
a potent neutrophil chemoattractant (Zeng et al., 2005) and 
plays an important role in preventing sepsis in the cecal liga-
tion model (Kelly-Scumpia et al., 2010). Therefore, defective 
IP-10 induction in PPs may be involved in rapid Y. entero­
colitica dissemination in TrifLPS2 mice after oral infection. Sec-
ond, TRIF is required for proper function of phagocytosis in 
uptake, as well as intracellular killing, during Gram-negative 
bacterial infection. Although MyD88 has been implicated in 
phagocytic function through activation of p38 mitogen-
activated protein kinase (Blander and Medzhitov, 2004), in-
volvement of TRIF signaling in phagocytic function has not 
previously been described. Others have suggested that TLR-
mediated  phagocytosis  depends  on  MyD88-independent   
p38 activation (Kong and Ge, 2008). TLR2xTLR4 double- 
deficient macrophages seem to have a more profound phago-
cytic  defect  than  MyD88-deficient  macrophages  (Blander 
and Medzhitov, 2004). Because the TRIF pathway can also 
activate p38, these results strongly support our observation 
that the phagocytosis of Gram-negative pathogens by macro-
phages involves the TRIF pathway.
At the center of the defect seen in TrifLPS2 mice is im-
paired  IFN-  production  by  infected  macrophages.  The   
hallmark of IFN- is its rapid production as a result of fast   
transcriptional  turnover  and  mRNA  accumulation  mediated 
through a feed-forward mechanism (Levy et al., 2003; Hall 
and Rosen, 2010). We found that the rapid induction of 
IFN- is important for inducing NK cells to produce IFN-, 
a potent antimicrobial cytokine which has previously been 
implicated  in  macrophage  activation  and  host  resistance 
against  a  variety  of  pathogens  including  Y.  enterocolitica 
(Autenrieth et al., 1996). We show that, in spite of normal 
TNF and IL-12p35 levels in the MLN of TrifLPS2 mice 
during the first 48 h after infection, TrifLPS2 mice do not   
produce optimal levels of IFN-. The major cell sources of 
IFN- and IFN- in the MLNs during Y. enterocolitica infec-
tion were macrophages and NK cells, respectively. These 
data indicate that macrophage TRIF signaling, and not just 
MyD88 signaling, is required for optimal induction of IFN- 
by NK cells to acquire the regional defense mechanism in the 
the MLN on day 7 of infection showed significant reductions 
in the colony numbers of Y. enterocolitica in all poly I:C–
treated mice regardless of the timing of injection (Fig. 8 C). 
None  of  the  mice  that  received  poly  I:C  had  detectable   
Y. enterocolitica colonization in the spleen.
To determine whether poly I:C treatment altered IFN- 
expression during the early stage of the infection, we exam-
ined the expression of IFN- in the MLN 48 h after infec-
tion (Fig. 8 C). All poly I:C–treated mice showed a significant 
increase in IFN- expression in the MLN compared with 
control mice. The protective effect of poly I:C (Fig. 8 D,   
d-1, poly I:C given 1 d before infection) was not observed in 
TrifLPS2 mice, confirming that the effect of poly I:C is medi-
ated through the TRIF pathway. The protective effect of 
poly I:C is not restricted to Y. enterocolitica infection, because 
poly I:C treatment (Fig. 8 E, poly d0, poly I:C treatment 
same day as infection) also reduced dissemination of S. typhi­
murium to the spleen at the 7 d of oral infection.
To further examine whether poly I:C treatment alters the 
natural history of Y. enterocolitica infection, we orally infected 
WT mice with a higher dose (3 × 108 CFU/mouse) of Y. entero­
colitica and examined the effect of poly I:C on mortality at   
28 d. The mortality rates of the mice that received poly I:C 
(Fig. 8 F, poly d-1 and poly d0) were significantly lower   
than the mortality in control mice. The mice that received 
poly I:C 1 d after infection (Fig. 8 F, poly d+1) demon-
strated reduced mortality, but the difference between control 
mice did not reach statistical significance. Blocking IFN- by   
the IFNAR1 antibody administered 1 d before infection abol-
ished the protective effect of poly I:C (d-1) on the mortality 
(Fig. 8 G). In vitro poly I:C treatment significantly enhanced 
bactericidal activity of WT peritoneal macrophages against 
Y. enterocolitica as well as S. typhimurium (Fig. 8 H). Collectively, 
systemic activation of the TRIF pathway protects the host 
against enteric Y. enterocolitica infection by enhancing IFN- 
expression in the MLN and macrophage bactericidal activity.
DISCUSSION
The development of effective strategies to protect the host 
against multiple types of pathogens is challenging. Because 
innate immune responses are antigen nonspecific, we became 
interested in how the innate immune response in the intes-
tine naturally protects against pathogens and whether strate-
gies could be developed to enhance innate immunity against 
enteric pathogens. Although TRIF is known as an antiviral 
signaling pathway downstream of TLR3, its role for antibac-
terial immunity has not been well studied. Using Y. entero­
colitica and S. typhimurium as model enteric pathogens, this 
study demonstrates an unexpected role for the TRIF path-
way in enteric infection by Gram-negative bacterial patho-
gens. Our results highlight an immunological model in which 
TLR4-mediated TRIF activation leads to the rapid induc-
tion of IFN- by macrophages, and IFN- in turn promotes 
IFN- production by NK cells that then feed back on the 
macrophages, enhancing their bactericidal activity. We chose 
to study these pathogens because they are enteric bacterial 2714 TRIF protects against enteric bacteria | Sotolongo et al.
2 = 11–14, 3 = >15. The full score is 9. Isolated MLN, PPs, and spleens 
were  homogenized  in  Ca2+  Mg2+  free  HBSS  (Cellgro)  and  cultured  in   
Yersinia selective agar (YSA; BD) plates at 28°C.
Macrophage bactericidal assay. Bactericidal assay was performed using 
our previously described method (Wiley et al., 2006). Peritoneal macrophages 
were isolated from mouse peritoneal lavage using sterile PBS. 2.5 × 105 macro-
phages were incubated for 48 h with DME containing 10% (vol/vol) FBS   
and 1% (vol/vol) PenStrep in a 24-well plate. PenStrep was removed before 
infection. Macrophages were then infected with Y. enterocolitica (MOI: 1) for 
30 min. Unattached Y. enterocolitica were washed out, and Y. enterocolitica asso-
ciated with the macrophages were collected by lysing macrophages with 500 µl 
of distilled water (0-h samples). Other wells were incubated for 6 h after 
washing out the unattached Y. enterocolitica, and samples were collected by 
lysing macrophages with distilled water (6-h samples). The same procedure 
was done for S. typhimurium infection. 100 U/ml of recombinant mouse 
IFN- (Hycult Biotech) or 5 µg/ml poly I:C (InvivoGen) were added to 
some wells. Those 0- and 6-h samples were plated on YSA plates. Data were 
expressed as fold increase relative to the mean CFU of 0 h samples.
NK cell isolation and macrophage co-culture. Splenic NK cells were 
isolated from WT mice using PE anti–mouse DX5 (eBioscience) and anti-
PE Multi-Sort kit (Miltenyi Biotec). For the IFN- production assay, peri-
toneal macrophages isolated from WT and TrifLPS2 mice were stimulated 
with 10 µg/ml poly I:C for 6 h and then washed to exclude poly I:C (Fig. 6 A). 
Isolated WT NK cells were co-cultured with the prestimulated macrophages 
for 24 h in the presence or absence of 10 µg/ml anti-IFNAR1 antibody.   
Supernatants were analyzed for IFN- concentration using ELISA.
A set of the co-culture was performed in the presence or absence of 
10 µg/ml of neutralizing anti-IFN- antibody (XMG1.2; eBioscience; 
Fig. 6 A). After 24 h of co-culture, NK cells were removed and remaining 
macrophages were infected with Y. enterocolitica at an MOI of 2. Bactericidal 
activity was analyzed as previously described.
Phagocytosis and flow cytometry. Y. enterocolitica, E. coli (K12 strain), or 
S. typhimurium were labeled with SYTO83 (Invitrogen) and opsonized with 
FBS  (Sigma-Aldrich).  Freshly  isolated  macrophages  were  infected  with 
SYTO83-labeled bacteria (MOI: 50) for 30 min. Red fluorescent–contained 
microspheres (2 µm diameter) were used as control (Cospheric LLC). Sub-
sequently, cells were washed with DME containing 1% (vol/vol) PenStrep 
and were analyzed by FACSDiva (BD).
The following antibody sets were used to identify IFN-expressing cell 
populations  in  the  MLN:  FITC  rat  anti–mouse  IFN-  (PBL  Interferon 
source), biotinylated rat anti–mouse F4/80 (Serotec) with PE streptavidin 
(BD), allophycocyanin (APC) hamster anti–mouse CD11c (eBioscience) and 
PE rat anti–mouse IFN- (eBioscience), FITC mouse anti–mouse NK1.1 
(CD161: eBioscience), and APC hamster anti–mouse CD3 (eBioscience).   
6 h before the isolation of the MLN and spleen, mice were i.p injected with 
250 µg Brefeldin A (eBioscience; Liu and Whitton, 2005). Intracellular IFN 
staining was performed using a Fixation and Permeabilization kit (eBiosci-
ence). IFN-positive cells were gated for surface marker analysis.
Real-time PCR. Total RNA was isolated from the MLN, spleen and PPs, and 
Y. enterocolitica–infected macrophages (MOI: 20) using RNA Bee (Tel-Test Inc). 
1 µg RNA was reverse transcribed using the Transcriptor First Strand cDNA syn-
thesis kit (Roche). All primers used are listed in Table S2. Primers for KC 
(CXCL1) were obtained from Applied Biosystems (Mm00433859_m1). Real-
time PCR was performed using SYBR Premix Ex Taq (Takara Bio) with a 
LightCycler 480 (Roche). Relative expression levels were calculated with the 
comparative 2Ct method using -actin as the endogenous control.
ELISA. Protein levels of IFN- and IFN- were determined in mouse serum 
or primary cell culture media by using DuoSet ELISA Development System 
(R&D Systems) according to the manufacturer’s instructions. The supernatant 
of MLN cell suspensions (2 × 106/ml) harvested 48 h after infection was mea-
sured for concentrations of IFN- and IFN- after 48 h of incubation.
MLN. Kinetic analyses of regional versus systemic cytokine 
responses to enteric Y. enterocolitica infection show robust 
IFN- induction both regionally and systemically. This in-
duction of IFN- was transient, as it was only observed be-
tween 48 and 72 h after infection. Yet, this induction of 
IFN- is necessary and sufficient to establish protective im-
munity downstream of TRIF. To substantiate this statement, 
we show that exogenous IFN- during the first 72 h of in-
fection can restore TrifLPS2 mice to a nearly normal ability to 
survive infection with Y. enterocolitica. Interestingly, a late in-
crease of regional and systemic TNF expression was observed 
in the minority of TrifLPS2 mice that survived Y. enterocolitica 
infection. No systemic induction of TNF was found in WT 
mice, presumably because IFN- was protective. TNF is a 
potent antimicrobial mediator but can have a systemic toxic-
ity (Autenrieth and Heesemann, 1992; Bhatia et al., 2009). 
These  results  suggest  that  TRIF-mediated  IFN-  orches-
trates effective immunity against enteric Y. enterocolitica infec-
tion, which regionally facilitates macrophage elimination of 
the pathogen and minimizes the needs for a systemic inflam-
matory response.
We show in this study a novel role of the TRIF pathway 
in induction of intestinal protective immunity against Gram-
negative bacterial infection. Our results are particularly excit-
ing because the pathway can be manipulated, and we show 
that it applies to more than one Gram-negative pathogen. 
Our results provide an important way to activate the host in-
nate immune response without causing systemic toxicity. We 
envision that targeting this pathway can be operationalized to 
treat patients within a window of infection.
MATERIALS AND METHODS
Mice  and  interventions.  TLR4/,  MyD88/  mice  and  C57BL/6J, 
TLR3/ mice were obtained from Oriental Bio Service, Inc. and The   
Jackson Laboratory, respectively. TrifLps2 mice were gifts from B. Buetler (Scripps 
Research Institute, La Jolla, CA). Mice were kept in specific pathogen-free 
conditions and fed by free access to diet and water. WT Y. enterocolitica  
(WA-314 serotype O:8) was used. S. typhimurium (SL1344) was a gift from   
A.T. Gewirtz and M. Vijay-Kumar (Emory University, Atlanta, GA). Mice 
were orogastrically inoculated with Y. enterocolitica or S. typhimurium (Echeverry   
et al., 2007). In some infections, Y. enterocolitica was labeled with red fluores-
cent dye (SYTO83) according to the manufacturer’s instructions (Invitro-
gen). Systemic infection was performed by a single injection of a sublethal 
dose of Y. enterocolitica (2 × 105 CFU) through the retro-orbital vein (Handley 
et al., 2004). The IFNAR1 antibody was administered 1 d prior infection 
(100 µg i.p./mouse; Leinco Technologies), and CHO cell–derived recombi-
nant IFN- was administered daily for the first 3 d of infection (10,000 U   
i.p/mouse; Hycult Biotech). This dose was based on serum IFN- levels mea-
sured in WT mice during infection. Poly I:C was s.c injected (50 µg/mouse; 
InvivoGen) as indicated. Rabbit anti–murine IP-10 antibody was adminis-
tered at the same time as infection (100 µg i.p/mouse; PeproTech; Liu et al., 
2001; Michalec et al., 2002). Protocols for animal experiments were approved 
by and performed according to the University of Miami Miller School of 
Medicine Animal Care and Use Committees’ guidelines.
Infected mice were monitored daily for body weight. Histological assess-
ment was performed by two veterinary pathologists. The scoring system used 
was: PPs and MLNs, 0 = normal, 1 = hyperplastic follicles, 2 = diffuse inflam-
matory  infiltrate,  3  =  necrosis  and  lymphocytic  depletion;  surrounding   
mucosa, 0 = normal, 1 = mild inflammatory infiltrate, 2 = moderate to 
marked infiltration, 3 = ulceration; area (percentage), 0 = <5, 1 = 5–10,   JEM Vol. 208, No. 13 
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Western blot analysis. 10 µg of lysate was subjected to 10% SDS–PAGE 
and transferred to Immobilon-PDVF membranes (Millipore). After block-
ing,  the  membrane  was  blotted  with  antibodies  against  phospho–IRF-3   
and IRF-3 (Cell Signaling Technology), followed by horseradish peroxi-
dase–conjugated goat anti–mouse (Sigma-Aldrich) and goat anti–rabbit IgG 
(Invitrogen), respectively. The membrane was exposed on radiographical 
film using SuperSignal West Dura kit (Thermo Fisher Scientific).
Immunohistochemistry. The 5-µm cryosections were incubated with 5% 
milk for 1 h and stained with rabbit anti–IFN- (1:100; Sigma-Aldrich) in 
combination with Alexa Fluor 488 anti–rabbit IgG (1:400; Invitrogen), or 
rat anti–mouse IFN- (1:80; BD) in combination with Alexa Fluor 568 
anti–rat IgG (1:400; Invitrogen) by overnight incubation at 4°C. To identify 
macrophages and DCs, sections were serially incubated with rat anti–mouse 
F4/80 (1:100; Serotec) and biotin anti–mouse CD11c (1:80; eBioscience) 
overnight at 4°C, followed by Alexa Fluor 568 anti–rat IgG and Alexa Fluor 
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4°C. Sections were incubated with 5% milk for 1 h before the incubation 
with each primary antibody. The specificity of staining was confirmed using 
isotype-matched control antibodies. Slides were examined using a confocal 
microscope (TCS-SP5; Leica).
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with  opsonized  Y.  enterocolitica,  E.  coli  (K12  strain),  or  S.  typhimurium  
(MOI: 50) and subsequently reacted with 10 µl Luminol (10 mM; Sigma- 
Aldrich) in a 96-well flat-bottom lumitrac plate (Greiner Bio One). Chemi-
luminescence was measured by a GloMax-96 Luminometer every 10 min 
with a 10-s integration per reading.
Statistics. Kaplan Meier survival curve was generated for infected mice. 
Student’s t test was used for two independent groups. One-way ANOVA 
was used for more than two independent groups. Fisher’s exact test was used 
to determine probability. All tests were performed with Prism (GraphPad 
Software), and a p-value of <0.05 was considered statistically significant.
Online supplemental material. Fig. S1 shows the results of intracellu-
lar killing assay. Fig. S2 shows caspase 3 activity in infected macrophages. 
Fig. S3 shows cytokine mRNA expression in PPs 48 h after Y. enterocolitica 
infection. Table S1 shows cell population analysis in PPs of uninfected mice. 
Table S2 shows primer sequences that were used in this study. Online 
supplemental material is available at http://www.jem.org/cgi/content/ 
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